Priya S. Chockalingam

Priya Chockalingam PhD, is Vice President and Head of Clinical BioAnalytics & Translational Sciences at Beam Therapeutics. She leads cross-functional strategies spanning bioanalytics, biomarkers, and translational medicine for a diverse clinical pipeline in hematology, immunology, oncology, and rare genetic diseases. Her work supports programs utilizing base editing, cell therapies (auto and allo), and advanced delivery platforms like lipid nanoparticles (LNPs). With over 25 years of experience, Priya has held key roles in translational medicine and diagnostics at Wyeth, Pfizer, Takeda, and Biogen, bringing deep expertise in bridging research and clinical development.